Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-032001
Filing Date
2023-09-07
Accepted
2023-09-07 17:25:10
Documents
4
Period of Report
2023-09-07

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 960696
2 formpre14a_001.jpg GRAPHIC 83300
3 proxy_001.jpg GRAPHIC 255739
4 proxy_002.jpg GRAPHIC 243488
  Complete submission text file 0001493152-23-032001.txt   1764501
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38286 | Film No.: 231243135
SIC: 2834 Pharmaceutical Preparations